Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Armata Pharmaceuticals (ARMP) Income from Continuing Operations (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Income from Continuing Operations for 6 consecutive years, with 1101000.0 as the latest value for Q4 2018.

  • Quarterly Income from Continuing Operations fell 122.68% to 1101000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was 10094000.0 through Dec 2018, down 75.67% year-over-year, with the annual reading at 53224000.0 for FY2025, 0.09% changed from the prior year.
  • Income from Continuing Operations hit 1101000.0 in Q4 2018 for Armata Pharmaceuticals, up from 2771000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 4854000.0 in Q4 2017 to a low of 11307000.0 in Q1 2014.
  • Historically, Income from Continuing Operations has averaged 3181050.0 across 5 years, with a median of 2961000.0 in 2015.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 691.25% in 2014 and later surged 231.26% in 2017.
  • Year by year, Income from Continuing Operations stood at 2597000.0 in 2014, then fell by 10.4% to 2867000.0 in 2015, then decreased by 28.99% to 3698000.0 in 2016, then soared by 231.26% to 4854000.0 in 2017, then plummeted by 122.68% to 1101000.0 in 2018.
  • Business Quant data shows Income from Continuing Operations for ARMP at 1101000.0 in Q4 2018, 2771000.0 in Q3 2018, and 3167000.0 in Q2 2018.